Literature DB >> 29782640

Drug-gut microbiota interactions: implications for neuropharmacology.

Jacinta Walsh1,2, Brendan T Griffin3,2, Gerard Clarke4,2, Niall P Hyland1,2,5.   

Abstract

The fate and activity of drugs are frequently dictated not only by the host per se but also by the microorganisms present in the gastrointestinal tract. The gut microbiome is known to, both directly and indirectly, affect drug metabolism. More evidence now hints at the effects that drugs can have on the function and composition of the gut microbiome. Both microbiota-mediated alterations in drug metabolism and drug-mediated alterations in the gut microbiome can have beneficial or detrimental effects on the host. Greater insights into the mechanisms driving these reciprocal drug-gut microbiota interactions are needed to guide the development of microbiome-targeted dietary or pharmacological interventions, which may have the potential to enhance drug efficacy or reduce drug side effects. In this review, we explore the relationship between drugs and the gut microbiome, with a specific focus on potential mechanisms underpinning the drug-mediated alterations on the gut microbiome and the potential implications for psychoactive drugs. LINKED ARTICLES: This article is part of a themed section on When Pharmacology Meets the Microbiome: New Targets for Therapeutics? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.24/issuetoc.
© 2018 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29782640      PMCID: PMC6255959          DOI: 10.1111/bph.14366

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  119 in total

Review 1.  Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery.

Authors:  Mohammad S Alavijeh; Mansoor Chishty; M Zeeshan Qaiser; Alan M Palmer
Journal:  NeuroRx       Date:  2005-10

2.  Reduction of nitrazepam by Clostridium leptum, a nitroreductase-producing bacterium isolated from the human intestinal tract.

Authors:  F Rafii; J B Sutherland; E B Hansen; C E Cerniglia
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

3.  The influence of probiotic treatment on sulfasalazine metabolism in rat.

Authors:  Hee Ji Lee; Hu Zhang; David A Orlovich; J Paul Fawcett
Journal:  Xenobiotica       Date:  2012-02-21       Impact factor: 1.908

4.  Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism.

Authors:  T Andrew Clayton; David Baker; John C Lindon; Jeremy R Everett; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

5.  Role of the intestinal microflora in clonazepam metabolism in the rat.

Authors:  G W Elmer; R P Remmel
Journal:  Xenobiotica       Date:  1984-11       Impact factor: 1.908

6.  Characterization of glycosaminoglycan (GAG) sulfatases from the human gut symbiont Bacteroides thetaiotaomicron reveals the first GAG-specific bacterial endosulfatase.

Authors:  Jonathan E Ulmer; Eric Morssing Vilén; Ramesh Babu Namburi; Alhosna Benjdia; Julie Beneteau; Annie Malleron; David Bonnaffé; Pierre-Alexandre Driguez; Karine Descroix; Gilbert Lassalle; Christine Le Narvor; Corine Sandström; Dorothe Spillmann; Olivier Berteau
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

7.  Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.

Authors:  Patrice D Cani; Rodrigo Bibiloni; Claude Knauf; Aurélie Waget; Audrey M Neyrinck; Nathalie M Delzenne; Rémy Burcelin
Journal:  Diabetes       Date:  2008-02-27       Impact factor: 9.461

Review 8.  The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations.

Authors:  Nuria Salazar; Silvia Arboleya; Lorena Valdés; Catherine Stanton; Paul Ross; Lorena Ruiz; Miguel Gueimonde; Clara G de Los Reyes-Gavilán
Journal:  Front Genet       Date:  2014-11-21       Impact factor: 4.599

9.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors.

Authors:  Stephen Ph Alexander; John A Cidlowski; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

10.  Extensive impact of non-antibiotic drugs on human gut bacteria.

Authors:  Lisa Maier; Mihaela Pruteanu; Michael Kuhn; Georg Zeller; Anja Telzerow; Exene Erin Anderson; Ana Rita Brochado; Keith Conrad Fernandez; Hitomi Dose; Hirotada Mori; Kiran Raosaheb Patil; Peer Bork; Athanasios Typas
Journal:  Nature       Date:  2018-03-19       Impact factor: 49.962

View more
  22 in total

1.  When pharmacology meets the microbiome: new targets for therapeutics?

Authors:  Niall P Hyland; John F Cryan
Journal:  Br J Pharmacol       Date:  2018-12       Impact factor: 8.739

Review 2.  Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder.

Authors:  Thomaz F S Bastiaanssen; Sofia Cussotto; Marcus J Claesson; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Harv Rev Psychiatry       Date:  2020 Jan/Feb       Impact factor: 3.732

3.  Molecular Characterization of Probiotics and Their Influence on Children with Autism Spectrum Disorder.

Authors:  Nagwa A Meguid; Youssef Imam A Mawgoud; Geir Bjørklund; Nayra Shakar Mehanne; Mona Anwar; Baher Abd El-Khalik Effat; Salvatore Chirumbolo; Manar Magdy Abd Elrahman
Journal:  Mol Neurobiol       Date:  2022-09-01       Impact factor: 5.682

Review 4.  Tryptophan Metabolites as Mediators of Microbiota-Gut-Brain Communication: Focus on Isatin.

Authors:  Alexei Medvedev; Olga Buneeva
Journal:  Front Behav Neurosci       Date:  2022-06-30       Impact factor: 3.617

Review 5.  The Gut Microbiome and Treatment-Resistance in Schizophrenia.

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2020-03

Review 6.  Does modern research validate the ancient wisdom of gut flora and brain connection? A literature review of gut dysbiosis in neurological and neurosurgical disorders over the last decade.

Authors:  Pranati Sharma; Abhishek Agrawal
Journal:  Neurosurg Rev       Date:  2021-04-26       Impact factor: 2.800

7.  The Potential of Gut Microbiota Metabolic Capability to Detect Drug Response in Rheumatoid Arthritis Patients.

Authors:  Maozhen Han; Na Zhang; Yujie Mao; Bingbing Huang; Mengfei Ren; Zhangjie Peng; Zipeng Bai; Long Chen; Yan Liu; Shanshan Wang; Shenghai Huang; Zhixiang Cheng
Journal:  Front Microbiol       Date:  2022-04-08       Impact factor: 6.064

Review 8.  The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women.

Authors:  Salim S Abdool Karim; Cheryl Baxter; Jo-Ann S Passmore; Lyle R McKinnon; Brent L Williams
Journal:  J Int AIDS Soc       Date:  2019-05       Impact factor: 5.396

Review 9.  Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal Microbiome.

Authors:  Joshua Bilello; Ikenna Okereke
Journal:  Biomedicines       Date:  2021-05-29

10.  Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.

Authors:  Lingyan Ma; Jing Keng; Min Cheng; Hua Pan; Bo Feng; Yongfeng Hu; Tao Feng; Fan Yang
Journal:  mSphere       Date:  2021-08-04       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.